Skip to content

The analgesic effects of preemptive analgesia starting at different time points after total knee arthroplasty: a prospective, double-blind randomized controlled trial

The analgesic effects of preemptive analgesia starting at different time points after total knee arthroplasty: a prospective, double-blind randomized controlled trial

Status
Recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2000035182
Enrollment
Unknown
Registered
2020-08-02
Start date
2020-09-01
Completion date
Unknown
Last updated
2021-03-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Osteoarthritis of the knee

Interventions

A:Preoperative analgesia was started 48 hours before surgery. Celecoxib was taken orally 200mg every time, once every 12 hours, and the last time was taken orally one hour before surgery.
B:Pre-operative analgesia was started 24 hours before surgery. Celecoxib was taken orally at 200mg each time, once every 12 hours, and the last time was taken orally one hour before surgery
C:Preoperative analgesia was started 1 hour before surgery, with 400mg of celecoxib administered orally

Sponsors

Department of Orthopaedics Surgery, West China Hospital, Sichuan University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. patients requiring unilateral initial TKA surgery due to severe knee osteoarthritis; 2. aged 40 to 80 years; 3. body mass index was 20~35 kg/m2; 4. the American Society of Anesthesiologists (ASA) classification (anesthesia risk assessment) I ~ III.

Exclusion criteria

Exclusion criteria: 1. Allergic to drugs used in this study; 2. there were more than moderate intraoperative knee malformations (pronation and flexion malformations) and joint stiffness; 3. alcoholic or long-term opioid users; 4. language impairment and inability to perform pain numerical scales (NRS); 5. surgical limb neuropathy; 6. mental patients; 7. patients with previous gastrointestinal ulcer.

Design outcomes

Primary

MeasureTime frame
Postoperative dosage of remedial morphine hydrochloride;VAS pain score;Range of knee motion;Quadriceps strength;Daily walking distance;Incidence of postoperative complications;Time to first straight leg raise;The duration of hospital stay;

Countries

China

Contacts

Public ContactPengde Kang

West China Hospital, Sichuan University

kangpengd@163.com+86 18280213153

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026